Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2024 le 14 Mai 2024
May 13, 2024 16:30 ET
|
Nyxoah
Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2024 le 14 Mai 2024 Mont-Saint-Guibert, Belgique – 13 mai 2024, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH)...
Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024
May 13, 2024 16:30 ET
|
Nyxoah
Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024 Mont-Saint-Guibert, Belgium – May 13, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or...
STRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1x1 Investor Conference
May 13, 2024 16:30 ET
|
STRATA Skin Sciences, Inc.
HORSHAM, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and...
FlexShopper, Inc. Reports 2024 First Quarter and Year End Financial Results
May 13, 2024 16:30 ET
|
FlexShopper, Inc.
BOCA RATON, Fla., May 13, 2024 (GLOBE NEWSWIRE) -- FlexShopper, Inc. (Nasdaq:FPAY) (“FlexShopper”), a leading national online lease-to-own (“LTO”) retailer and payment solution provider for...
Stran & Company Postpones 2024 First Quarter Earnings Conference Call
May 13, 2024 16:30 ET
|
Stran & Company, Inc.
Quincy, MA, May 13, 2024 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its...
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
May 13, 2024 16:30 ET
|
Tonix Pharmaceuticals Holding Corp.
On track to submit NDA in the second half of 2024 for Tonmya™ for fibromyalgia; pre-NDA meeting with FDA scheduled for second quarter 2024 Commercial planning continues for U.S. launch of Tonmya, a...
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
May 13, 2024 16:30 ET
|
Aerovate Therapeutics, Inc.
Topline data expected in June 2024 from Phase 2b portion of the IMPAHCT global Phase 2b/Phase 3 clinical trial of AV-101 for pulmonary arterial hypertension (PAH) Enrollment continues into the Phase 3...
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
May 13, 2024 16:30 ET
|
Sutro Biopharma, Inc.
- Investigational New Drug application for non-small cell lung cancer trial with luvelta cleared by U.S. Food and Drug Administration; Phase 2 on track to begin dosing in the second half of 2024 - ...
Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 13, 2024 16:30 ET
|
Cartesian Therapeutics, Inc.
GAITHERSBURG, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune...
Territorial Bancorp Inc. Declares Dividend
May 13, 2024 16:30 ET
|
Territorial Bancorp Inc.
HONOLULU, May 13, 2024 (GLOBE NEWSWIRE) -- Territorial Bancorp Inc. (NASDAQ: TBNK) (the “Company”), headquartered in Honolulu, Hawaii, the holding company parent of Territorial Savings Bank,...